BCL2 and B-cell non-Hodgkin lymphoma: High-grade B-cell lymphoma with translocations of MYC and BCL2 and/or BCL6 genes has been associated with a worse prognosis [5,13], whereas mutations such as MYD88 and CD79B have been frequently described in PCNSL [11].